Immunopar Liquid
NDC Package 44911-0636-1
Package Information
Immunopar (astragalus membranaceus, baptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, lymph node (suis), medulla ossis suis, mucosa nasalis suis, spleen (suis), thymus (suis), anas barbariae, hepatis et cordis extractum, arsenicum album, lachesis mutus, phosphorus, pyrogenium) liquids May temporarily relieve Painful, irrated throat, mild ear disorders, and minor bronchial irritation with yellow expectoration.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0636.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- ASTRAGALUS PROPINQUUS ROOT 3 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 3 [hp_X]/mL
- CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE 12 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 3 [hp_X]/mL
- GOLDENSEAL 6 [hp_X]/mL
- LACHESIS MUTA VENOM 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- RANCID BEEF 30 [hp_X]/mL
- SUS SCROFA BONE MARROW 6 [hp_X]/mL
- SUS SCROFA LYMPH 6 [hp_X]/mL
- SUS SCROFA NASAL MUCOSA 6 [hp_X]/mL
- SUS SCROFA SPLEEN 6 [hp_X]/mL
- SUS SCROFA THYMUS 6 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0636 - Immunopar
- 44911-0636-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0636 - Immunopar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0636-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Immunopar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; astragalus propinquus root; baptisia tinctoria root; cairina moschata heart/liver autolysate; echinacea angustifolia whole; goldenseal; lachesis muta venom; phosphorus; rancid beef; sus scrofa bone marrow; sus scrofa lymph; sus scrofa nasal mucosa; sus scrofa spleen; sus scrofa thymus as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on May 19, 2021. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911063601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.